Deborah Berry, PA
Surgical · Bridgeport, CTNPI 1457880049
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,027 of the $2,574 with a category attached, or 78.8%. It is spread thinly across 24 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $31.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$560
- Novartis$336
- Bristol Myers Squibb$335
- AbbVie$189
- Seagen Inc.$185
- Amgen$183
- plus $786 from 18 others
What the payments were for
- Food & beverage$2,02779%
- Education$54721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $560 |
| Novartis | 10 | $336 |
| Bristol Myers Squibb | 15 | $335 |
| AbbVie | 7 | $189 |
| Seagen Inc. | 2 | $185 |
| Amgen | 2 | $183 |
| AstraZeneca(2 entities) | 5 | $99 |
| Merck | 4 | $84 |
| Gilead | 1 | $83 |
| Array Biopharma Inc | 3 | $64 |
| Mirati Therapeutics, Inc. | 2 | $55 |
| Pfizer | 3 | $54 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Incyte Corporation | 2 | $46 |
| Bayer | 2 | $41 |
| AVEO Pharmaceuticals, Inc. | 1 | $36 |
| Rigel Pharmaceuticals, Inc. | 1 | $28 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $26 |
| Eisai Inc. | 1 | $24 |
| Pharmaessentia USA Corporation | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Geron Corporation | 1 | $20 |
| Morphosys, US Inc. | 1 | $16 |
| Sobi, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,574 in reported general payments places this provider in the 90th percentile of 568 surgical providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 17 | $382,628 |
| EliquisApixaban | 33 | $24,044 |
| Potassium Chloride | 24 | $702 |
| Hydroxyurea | 27 | $484 |
| Ondansetron OdtOndansetron | 49 | $361 |
| Anastrozole | 29 | $340 |
| Acyclovir | 26 | $318 |
| Pantoprazole Sodium | 16 | $291 |
| Hydroxyzine Hcl | 13 | $239 |
| Gabapentin | 24 | $221 |
| Triamcinolone Acetonide | 11 | $204 |
| LoperamideLoperamide Hcl | 25 | $203 |
| Dexamethasone | 31 | $173 |
| Prochlorperazine Maleate | 11 | $165 |
| Lorazepam | 36 | $165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $335 | $382,62817 claims |
| PfizerEliquis | $54 | $24,04433 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 568 surgical providers in Connecticut.
Other surgical in Bridgeport
- Megan StrongBridgeport$11K
- Angela PredaBridgeport$5K
- John LignoreBridgeport$2K
- Erin Myers AlbaridiNorwalk$70K
- Christopher MascioStamford$44K
- Scott CallahanMonroe$31K
- Monika Hoang-SkawinskaMiddletown$17K
- Danielle MundayNorwalk$13K
- Ryan ArtigliereNew Haven$10K
- Arya BiswasNorwich$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.